Santis Pedicle Screw System receives FDA approval



SAINT GALLEN – January 16th 2014 – Lanterna Medical Technologies GmbH.

Lanterna Medical Technologies, a medical device company focused on developing innovative, intuitive and cost effective solutions for the surgical treatment of human skeletal disease, announced today, that the company has received clearance from the FDA to market their SANTIS™ PEDICLE SCREW SYSTEM in the United States.

Mr. Horace Hale, President of Lanterna said:

¨This approval signals the start of the Company’s participation in the world’s largest spine market and I applaud our regulatory team who worked diligently to achieve this milestone within such a short timeframe.

We are excited about bringing to this theatre of operations, an implant system that will provide surgeons with the unprecedented ability to treat a wide range of pathologies, while offering unparalleled ease of use.

We are absolutely thrilled to offer SANTIS™ in America, this dovetails perfectly with our strategy of focusing on minimally disruptive approaches globally.

SANTIS™ is an intuitive solution with widely accepted guide technology, superior rod insertion options, and innovative reduction capabilities.

We have our sights set on making an impact on the delivery and outcomes of spine surgery in the USA, an exciting new market for us. The approval and subsequent launch of SANTIS™, will afford us the opprtunity to introduce US spine surgeons to additional innovation within our portfolio of transformational spine solutions as they too are cleared for use.

I am confident and excited about our future prospects in this arena of considerable opportunity.”